Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Journal of Neuroimmunology|July 9, 1998
Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus)J D Laman, M van Meurs, M M Schellekens, et al.
British Journal of Rheumatology|January 1, 1996
Increased expression of interferon (IFN)-gamma together with IFN-gamma receptor in the rheumatoid synovial membrane compared with synovium of patients with osteoarthritisR J Dolhain, N T ter Haar, S Hoefakker, et al.
The American Journal of Physiology|October 1, 1995
Differential sympathetic nerve responses to nitric oxide synthase inhibition in anesthetized ratsT Hirai, T I Musch, D A Morgan, et al.
The Journal of Experimental Medicine|November 1, 1993
In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactionsA J Van den Eertwegh, R J Noelle, M Roy, et al.
Contact Dermatitis|October 1, 1995
In vivo cytokine profiles in allergic and irritant contact dermatitisS Hoefakker, M Caubo, E H van 't Erve, et al.
Immunology|February 1, 1995
Activated rat T cells synthesize and express functional major histocompatibility class II antigensC P Broeren, M H Wauben, M A Lucassen, et al.
The Journal of Pathology|April 1, 1990
Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistryJ A de Winter, J Trapman, A O Brinkmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1995
Requirement of CTLA-4 counter receptors for IL-4 but not IL-10 elevations during a primary systemic in vivo immune responseP Lu, X D Zhou, S J Chen, et al.
Journal of Lipid Research|February 1, 1992
Immunological discrimination between the human apolipoprotein E2(Arg158----Cys) and E3 isoformsK Gerritse, P de Knijff, G van Ierssel, et al.
Journal of Virology|March 1, 1992
Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domainJ D Laman, M M Schellekens, Y H Abacioglu, et al.
Pageof 14